Investigating the Correlation between LPR & Obesity
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Objectives: To determine whether Drug-Induced Sleep Endoscopy (DISE) findings of
Laryngopharyngeal Reflux (LPR) correlate with obesity, gender, Epworth Sleepiness scale, and
OSA severity.
Study design: Single center retrospective cohort study.
Methods: Patients greater than 18 years of age who underwent DISE by one surgeon at a
tertiary care center from July 2016 to July 2022 were included. DISE findings, patient
characteristics, demographics, polysomnogram(s), and Epworth Sleepiness Scale(s) were
extracted. Fisher’s exact test was used to compare categorical variables, and independent
sample t-test was used to compare continuous variables. All statistical analyses were
performed using IBM SPSS Statistics 28.
Results: The study included 178 patients (60.87 years ± 11.54; 31.24 BMI ± 6.21). 38 patients
had LPR, and 103 patients had a BMI>30. LPR+ patients BMI was 33.11 ± 5.60, and LPR- patients
BMI was 30.74 ± 6.28. There was a statistically significant relationship between obesity and LPR
(p = 0.005). Additionally, obesity mild-moderately affected patients having LPR (d = .404).
There was no statistically significant difference between LPR+ patients and ESS, AHI, and gender
(p = .395, .174, & .302 respectively).

Conclusion: DISE aids in the diagnosis and evaluation of Obstructive Sleep Apnea (OSA) by
simulating natural sleep. Using this highly precise diagnostic procedure, our study shows a
relationship between findings of LPR in obese patients with obesity playing a small-medium
role. There was no difference between LPR and ESS, AHI, and gender.
Introduction: Obstructive Sleep Apnea (OSA) is characterized by episodes of complete or partial
airway collapse, with an associated decrease in oxygen saturation or sleep arousal. OSA in the
adult population is categorized into three different categories based on the Apnea-Hypopnea
Index (AHI) events per hour. Mild OSA corresponds to an AHI 5 to less than 15. Additionally,
moderate OSA corresponds to an AHI of 15 and less than 30, and severe OSA is an AHI greater
than 30. Though population estimates vary significantly, the burden of moderate-to-severe OSA
in the United States is thought to be somewhere between 3-17% of the population1. For
patients with mild OSA, epidemiological estimates increase to 37-50%2. OSA correlates with
high levels of comorbidities such as hypertension, diabetes, depression, anxiety, coronary
artery disease, and myocardial infarction3,4,5. Hypersomnolence-induced traffic accidents are
also a concern for those suffering from OSA. These patients suffer from a lack of restful sleep
and severe daytime sleepiness6. OSA affects males at a higher rate than females, but
postmenopausal females are at a higher risk compared to other females4.
Continuous Positive Airway Pressure (CPAP) is still the gold standard medical treatment for
OSA; however, adherence rates are relatively low, ranging between 30 and 60%7. Therefore,
many patients seek alternatives, including surgical treatment. Due to this trend, Drug Induced
Sleep Endoscopy (DISE) has become a highly utilized procedure to identify levels of collapse
that ENT sleep surgeons can treat. DISE closely mimics what is occurring during normal sleep by

intravenous anesthetics such as midazolam and propofol. This procedure identifies the levels of
collapse with great confidence8. However, there are concurrent DISE findings discovered
incidentally during the procedure, of which the frequency, variety, and relationships between
findings, have not been elucidated yet. One such concurrent finding is Laryngopharyngeal
Reflux (LPR), which occurs when gastric contents irritate the vocal cords and can cause a sore
throat3. The aim of this study was to determine whether DISE findings of LPR correlate with
obesity and if so, what the effect of obesity is on causing LPR. We also desired to determine if
the severity of sleep apnea in our cohort, as measured by AHI, was worsened in the LPRpositive group compared to the LPR-negative group. Secondary parameters included analysis of
gender and Epworth Sleepiness Scale (ESS).
Methods: Patients greater than 18 years of age who underwent DISE by one surgeon at a
tertiary care center from July 2016 to July 2022 were included. DISE findings, patient
characteristics, demographics, polysomnogram(s), and Epworth Sleepiness Scale(s) were
extracted. Fisher’s exact test was used to compare categorical variables, such as LPR diagnosis
and obesity, and independent sample t-test was used to compare continuous variables such as
ESS, AHI, and BMI. All statistical analyses were performed using IBM SPSS Statistics 28.
Results: The study included 178 patients (60.87 years ± 11.54; 31.24 BMI ± 6.21). 38 patients
(21.3%) had LPR, and 103 patients (57.9%) were obese. Mean LPR-positive patient BMI was
33.11 ± 5.60, and mean LPR-negative patient BMI was 30.74 ± 6.28. There was a statistically
significant relationship between obesity and LPR diagnosis upon DISE (p = 0.005) using a onetailed test and assuming equal variances, with a Chi-square value of 6.746. Additionally, an
independent sample t-test generated an effect size of d = 0.404 via Cohen’s d test, which

showed a small-to-medium effect size of obesity on developing LPR. When comparing LPRpositive and LPR-negative patients, we saw no statistically significant difference in ESS, with the
mean score (scored from 0 to 24) increasing from 11.05 in our LPR-negative cohort to 11.32 in
our LPR-positive cohort (p = 0.395). We also saw no statistically significant difference between
AHI scores, with the mean score of events per hour increasing from 37.67 in our LPR-negative
cohort to 41.43 in our LPR-positive cohort. There was also no statistically significant difference
between genders (p = 0.302). For complete data, refer to Figures 1-6.
Discussion & Conclusion: LPR and obesity have been shown to have a relationship previously,
where LPR is more severe in obese patients9 but until this point, correlation between obesity
and LPR diagnosis upon DISE in OSA patients had yet to be clarified. Also, by generating an
effect size of d = 0.404 via Cohen’s d test, this study was the first to show a small-medium effect
size of obesity on LPR likelihood in OSA patients. A previous systematic review had found that
rates of laryngopharyngeal reflux in OSA patients ranged from 30.6-89.2%3, which is
considerably different than the rate found in this study of 21.3%. The means of diagnosis and
screening varied between studies where Reflux Symptom Index (RSI) was sometimes used as a
non-procedural method of LPR diagnosis3. Further research would help to clarify the rate at
which LPR occurs in the OSA population. Future work as an extension from this project would
be analyzing the rate of occurrence of LPR with other concurrent findings and measures of
obstruction, such as Lingual Tonsillar Hypertrophy, laryngomalacia, macroglossia,
tracheomalacia, laryngeal polyps, vocal cord nodules, as well as their specific areas of collapse.
Additionally, it would be of interest to determine if any significant differences between race or
socioeconomic status existed in terms of LPR occurrence. Further data collection of patients

undergoing DISE as well as extending our statistical analyses on the existing cohort of patients
would help improve both the power and the scope of our study.
Figure 1. Expected levels of LPR and Obesity within our cohort

Figure 2. Mean BMI comparison between LPR-positive and LPR-negative cohorts

Figure 3. Statistical significance of LPR and Obesity relationship

Figure 4. Pre-operative AHI levels between LPR-positive and LPR-negative cohorts

Figure 5. ESS levels between LPR-positive and LPR-negative cohorts

Figure 6. Calculated effect size of obesity on LPR within our cohort
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